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 A stochastic two-stage cancer model with clonal expansion was used to investigate the
potential impact on human lung cancer incidence of some aspects of the hormesis mech-
anisms suggested by Feinendegen (Health Phys. 52 663–669, 1987). The model was applied
to low doses of low-LET radiation delivered at low dose rates. Non-linear responses arise
in the model because radiologically induced adaptations in radical scavenging and DNA
repair may reduce the biological consequences of DNA damage formed by endogenous
processes and ionizing radiation. Sensitivity studies were conducted to identify critical
model inputs and to help define the changes in cellular defense mechanisms necessary to
produce a lifetime probability for lung cancer that deviates from a linear no-threshold
(LNT) type of response. Our studies suggest that lung cancer risk predictions may be very
sensitive to the induction of DNA damage by endogenous processes. For doses compara-
ble to background radiation levels, endogenous DNA damage may account for as much as
50 to 80% of the predicted lung cancers. For an additional lifetime dose of 1 Gy from low-
LET radiation, endogenous processes may still account for as much as 20% of the pre-
dicted cancers (Fig. 2). When both repair and scavengers are considered as inducible,
radiation must enhance DNA repair and radical scavenging in excess of 30 to 40% of the
baseline values to produce lifetime probabilities for lung cancer outside the range expect-
ed for endogenous processes and background radiation.
Keywords: radioprotective mechanisms, low-LET, lung cancer, LNT, threshold, hormesis, endogenous
damage
INTRODUCTION
There are biological responses to a variety of chemical and radiologi-
cal agents that may be U-shaped rather than LNT (Calabrese and Baldwin
2003). Azzam et al. (1996) demonstrated that low doses (1-100 mGy) of γ-
rays, when delivered at 2.4 mGy min–1, reduced the neoplastic transforma-
tion frequency in C3H 10T1/2 cells to a rate three- to four-fold below the
spontaneous transformation frequency. This has been confirmed in
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human-hybrid cell systems (Redpath and Antoniono 1998, Redpath et al.
2001, 2003a, 2003b). In animals in vivo, low doses have been shown to
reduce tumor frequency (Ishii et al. 1996) and increased both radiation-
induced and spontaneous tumor latency (Mitchel et al. 1999, 2003).
These results demonstrate that low-dose exposures may induce processes,
such as adaptations in DNA repair processes (Le et al. 1998, Ye et al. 1999),
radical scavenging (Yamaoka et al. 1991, Yukawa et al. 1999) or apoptosis
(Bauer 1995, 1996, 2000) that reduce the overall rate of cell transforma-
tion. In addition to the in vitro and animal in vivo studies, a review of
human epidemiological studies suggests that protracted exposure to low
doses of low-LET radiation does not appear to cause lung cancer and a
reduction of the natural cancer incidence level may even be evident
(Rossi and Zaider 1997).
In an earlier study (Schöllnberger et al. 2004), the concept of radio-
logically induced adaptations that also prevent and repair endogenous
(oxidative) DNA damage was developed using a deterministic 3-stage
lung cancer model. In this work, we develop methods of incorporating
these mechanisms into a stochastic two-stage cancer model. In a deter-
ministic model the hazard rate increases indefinitely while in a stochastic
cancer model it levels off at advanced ages (Heidenreich and
Hoogenveen 2001, Chen 1993). The trends predicted by stochastic mod-
els are consistent with observations suggesting that lung cancer incidence
and mortality rates increase with age, but start to level off at advanced age
and (for many cancers) decline at very high ages (see e.g., Benson 1996,
Herrero-Jimenez et al. 2000). 
The aim of the current study is to define the magnitude of the changes
in DNA damage repair and enzymatic radical scavengers that would be
required to produce a lifetime probability for lung cancer that deviates
from a linear no-threshold (LNT) type of response. Studies are presented
for hypothetical exposure scenarios in which individuals are exposed to
low doses rates of low-LET radiation in addition to natural background
radiation. The reported studies are most appropriate when high-LET radi-
ations, such as α particles from radon progeny, are a minor component of
the natural background radiation. Although continuous exposure to low
dose rates of low-LET radiation are not typical of many environmental
exposure settings, this type of exposure setting is a reasonable facsimile of
the types of exposures that may be encountered by workers in nuclear
power plants or other radiation facilities. The reported studies are the first
to consider the effects that radiation-induced adaptations in cellular
defense mechanisms have on predictions of lung cancer incidence made
with a stochastic multistage model. The approach developed in this work
is an important first step in developing new models and methods to
describe dose-response relations that deviate from the LNT response mod-
els that are widely used for radiation protection purposes.
Radioprotective mechanisms within a two-stage cancer model
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MATERIALS AND METHODS
Key aspects and the mathematical properties of stochastic two-stage
cancer models have been extensively discussed in the literature
(Moolgavkar 1979, Moolgavkar and Venzon 1979, Moolgavkar and
Knudson 1981, Moolgavkar and Luebeck 1990, Tan 1991, Little 1995,
Heidenreich 1996, Heidenreich et al. 1997a, 1997b). Figure 1 shows an
idealized schematic of the two-stage model. In this model, normal cells
(N-cells) are converted to initiated cells (I-cells) at the stochastic rate µ1.
Initiated cells complete mitosis and produce two progeny cells at sto-
chastic rate α and die or differentiate at stochastic rate β. In addition, ini-
tiated cells can also divide into one initiated and one malignant cell (M-
cell) at stochastic rate µ2. Malignant cells develop into a detectable tumor
mass after a non-stochastic lag time, tlag, for which a value of 5 years is used
(Leenhouts 1999). The net clonal expansion rate of initiated cells, α-β, is
assumed to be independent of dose and dose-rate. In the model, radia-
tion and endogenous processes can damage the DNA of target cells in the
lung. Some fraction of the misrepaired or unrepaired DNA damage
induces genomic instability and leads to the accumulation of initiated
and malignant cells.
To examine the potential significance of radioprotective mechanisms,
dose and dose rate dependent DNA repair and radical scavenging phe-
nomena are incorporated into the model. Changes in DNA repair and
radical scavenging with dose rate (and hence dose) are modeled using
dimensionless scaling-functions, denoted G and F, respectively. For values
of G and F greater than one, radiation is less effective at inducing genom-
ic instability and cell transformation (i.e., reduces the rate µ1). Rate µ1 is
parameterized as follows (Schöllnberger et al. 2004)
µ1 =
Ω Σ ϕi (Σ iendo + Σ irad ·D). (1)G( ·D) i F( ·D)
Here, Ω is the probability that a mutation formed at a random location
in the DNA induces genomic instability by modifying the expression or
 
FIGURE 1 Conceptual overview of the two-stage cancer model with clonal expansion. See the text
for explanation of the symbols.
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function of a critical gene. ϕi is the probability the i th type (simple or
complex) of lesion is misrepaired. Σ iendo is the expected number of i th
type lesion created by endogenous processes (cell–1 year–1), and Σ irad is the
expected number of i th type lesion created by radiation (mGy–1 cell–1),
the dose rate, 
·
D , is the total delivered dose divided by a lifespan of 75
years. Both, G(
·
D) and F(
·
D), have the following form
G(
·
D) = A{1 + Bexp[–C( ·D –  ·Dm)2]}. (2)
A, B and C are adjusted so that G and F take on modified Gaussian
forms. For  
·
Dm two different values were used: 2.67 and 4 mGy yr
–1. This
results in maxima of G(
·
D) and F(
·
D) at these indicated dose-rates, respec-
tively at the associated lifetime doses of 200 and 300 mGy (Schöllnberger
et al. 2004). This means that the maximum adaptive protection due to
changes in the misrepair probability, ϕi, and the radical scavenging
capacity of a cell will occur at dose rates of 2.67 and 4 mGy yr–1. These
values were chosen to reflect different hypothetical exposure scenarios
where doses of 200 or 300 mGy of low-LET radiation are delivered at low
dose rates in addition to background radiation. The 200 to 300 mGy
delivered in these exposure scenarios correspond to the extra dose of
radiation a worker might receive while working in, for example, a
nuclear power plant.
The exact tumor incidence formula in closed form developed for the
stochastic two-stage model by Kopp-Schneider et al. (1994) has been
applied. A lag-time was introduced into their formula that was then used
to calculate the lifetime probability for lung cancer. In another study
(Schöllnberger et al. 2004), a deterministic 3-stage cancer model was used
to identify model parameters consistent with the ICRP-derived risk coef-
ficient (0.85 × 10–2 Sv–1) for fatal lung cancer (ICRP 1991). A similar
methodology was used to identify parameters for the stochastic cancer
model. All parameter values were taken from Table 1 in Schöllnberger et
al. (2004) except for the following: ϕcl = 0.4937, Σclendo = 0 cell–1 yr–1, µ2 =
10–9 yr–1, α = 0.05 yr–1, β = 0 yr–1. The first three values were found by fit-
ting the model solution to the ICRP-derived values for the lifetime prob-
ability for lung cancer at lifetime doses of 75, 225, and 1000 mGy. The
value for α reflects the difference of earlier applied values for the mitot-
ic rate and the cell death and differentiation rate for initiated cells
(Schöllnberger et al. 2004). With β = 0, α is the net clonal expansion rate
of initiated cells.
RESULTS
Fig. 2 shows the lifetime probability for lung cancer at an age of 75
years versus the total absorbed dose delivered in the same time span. The
corresponding dose-rates range from 0 to 13.33 mGy/yr. The solid and
Radioprotective mechanisms within a two-stage cancer model
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dotted curves show the predicted lifetime probability of lung cancer
obtained with the stochastic and deterministic 3-stage cancer model,
respectively. The dashed curve shows the predicted lifetime probability
for radiation alone (i.e., Σ endocomplex = Σ endosingle = 0). Fig. 3 illustrates the effects
that radiation-induced adaptations in DNA damage repair (panel A) and
radical scavenging (panel B) may have on the lifetime probability for
lung cancer at an age of 75 years. The x-axis in Fig. 3 gives the lifetime
dose from low-LET radiation. The results in Fig. 3 refer to
·
Dm = 2.67 mGy
yr–1, i.e., we assumed that maximum gene induction occurs at 2.67 mGy
yr–1 from low-LET radiation which is delivered in addition to a very low
lifetime dose of background radiation. Fig. 4 shows the combined effects
for two values of
·
Dm (2.67 and 4 mGy yr
–1) and with various maxima in G
and F.
DISCUSSION
For doses comparable to background radiation levels, the results
shown in Figure 2 suggest that endogenous DNA damage accounts for as
much as 54 to 78% of the predicted lung cancers. For a lifetime dose of
1 Gy, endogenous processes may still account for as much as 21% of the
predicted cancers (Fig. 2). The shape of the lifetime probability of lung
cancer is very similar for both the stochastic and deterministic cancer
FIGURE 2 Contribution to the lifetime probability for lung cancer of DNA damage formed by
endogenous processes and ionizing radiation. Protective effects are not included in this set of calcu-
lations (i.e., F = G = const. = 1). Solid curve: stochastic cancer model with DNA damage formed by
ionizing radiation and endogenous processes. Dotted curve: deterministic 3-stage cancer model with
DNA damage formed by ionizing radiation and endogenous processes (Schöllnberger et al. 2004).
Dashed curve: stochastic model without any endogenous DNA damage (Σendocomplex = Σendosingle = 0). The ver-
tical dotted lines indicate the typical dose range expected from naturally occurring radiation sources,
i.e., background radiation. The lower dose bound is set at 75 mGy (1 mGy yr–1), and the upper dose
bound is set at 225 mGy (3 mGy yr–1).
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models (Fig. 2). Sensitivity studies highlight the importance of including
endogenously formed DNA damage in estimates of low-dose cancer inci-
dence levels (Fig. 3). The results in Fig. 3, panel A, suggest that radiation
must induce changes in DNA repair of at least 50% (G > 1.5) of the base-
line value in order to produce cumulative probability levels for lung can-
cer outside the range expected for endogenous processes and back-
ground radiation. For scavengers (panel B) the changes must be at least
200% (F > 2) to lead to significant deviations in the dose-response curves
for lifetime probability for lung cancer.
Depending on the chosen values used for
·
Dm, the model predicts
effective cancer incidence thresholds from 300 mGy (4 mGy yr–1 for 75
years) up to approximately 375 mGy (5 mGy yr–1 for 75 years) (Fig. 4).
The results in Fig. 4 suggest that radiation must induce changes in radi-
cal scavenging and DNA repair greater than about 30 or 40% (F and G >
1.3 to 1.4) of the baseline values in order to produce cumulative proba-
bility levels for lung cancer outside the range expected for endogenous
processes and background radiation. Some experiments suggest that, in
non-dividing cells, DNA repair remains at some baseline level until a
threshold dose is exceeded (Marples et al. 2002, Oudalova et al. 2002,
Rothkamm and Löbrich 2003, Zaichkina et al. 2003). Fig. 4, panel B,
shows the response expected if DNA repair and radical scavenging
remain at a baseline level until a threshold dose on the order of 150 mGy
is exceeded. Others, however, found that doses as low as 1 mGy induce
the full adaptive response (Broome et al. 2002). The 150 mGy threshold
for the induction of adaptive protection is a model prediction for a
·
Dm-
value of 4 mGy yr–1. Model predictions such as those shown in Fig. 4
FIGURE 3 Effects of cellular adaptations in DNA repair (panel A) and enzymatic radical scavenging
(panel B) on the lifetime probability of lung cancer at an age of 75 years for various doses of low-LET
radiation which is delivered in addition to a very low lifetime dose of background radiation.
·
Dm = 2.67
mGy yr–1, i.e., it is assumed that maximum gene induction occurs at 2.67 mGy yr–1 from low-LET radi-
ation which corresponds to a lifetime dose of 200 mGy.
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appear counter to some available epidemiological data for solid cancers
(Pierce and Preston 2000, Brenner et al. 2003) but find support by others
(Rossi and Zaider 1997). Our predictions are also consistent with the
findings of Azzam et al. (1996), Redpath and Antoniono 1998, Redpath et
al. 2001, 2003a, 2003b) for neoplastic transformation in vitro. In vitro
assays of neoplastic transformation have been shown to have relevance to
radiation carcinogenesis in vivo (Little 1989). In addition, Redpath et al.
(2001) found a remarkable similarity between the relative risks calculated
from their in vitro studies to those from various epidemiological studies
(Thompson et al. 1994), particularly for breast cancer (Miller et al. 1989)
and leukemia (Preston et al. 1994, Little et al. 2000).
The 30 to 40% change in DNA repair and scavenging used in the
modeling studies are consistent with the results of several experiments.
Le et al. (1998) report an app. 2-fold enhanced repair response for radia-
tion-induced DNA base damage. The increased rate of lesion removal was
caused by a 0.25 Gy dose of γ-radiation. Azzam et al. (1994) showed that a
dose of 0.5 Gy of γ-radiation (0.56 mGy/min) enhances the rate of DNA
repair in human fibroblasts by app. 30%. The same group also showed
that even 1 or 10 mGy doses (2.4 mGy/min) lead to the same significant
reduction of the neoplastic transformation frequency in C3H 10T1/2
cells below the spontaneous transformation frequency than a 100 mGy
dose (Azzam et al. 1996). This indicates that a low dose of 1 mGy can also
cause adaptive protections to a very similar degree as the one reported
for 0.5 Gy. Yukawa et al. (1999) demonstrated a transient increase in liver
cytosolic radical scavenging ability after an in vivo low dose irradiation of
rats. The maximum level of induction (app. 20%) was found around 5 to
10 cGy (35 cGy/min) of X-rays (Yukawa et al. 1999). It should be empha-
FIGURE 4 Predicted shapes of the lifetime lung cancer probability curves when both cellular
defense mechanisms (inducible DNA repair and radical scavenging) are included in the model.
Panel A:
·
Dm = 2.67 mGy yr
–1; panel B:
·
Dm = 4 mGy yr
–1.
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sized that the dose rates applied in these experiments are considerably
higher than those considered in the simulation studies reported in this
work. Additional experimental work for lower dose rates is desirable.
To better model the types of radiation exposures encountered in the
workplace, the proposed model needs to be extended so that time-
dependent changes in DNA repair and radical scavenging caused by a
specified dose of low-LET radiation delivered in a few minutes or hours
can be simulated. The current approach is limited to low doses of low-
LET radiation delivered at very low dose rates (i.e., dose rates compara-
ble to background radiation levels). Methods to incorporate cellular
defense mechanisms into biologically based neoplastic transformation
models (Scott et al. 2003, 2004) and cancer models (Bogen 2001) are
important to future developments in radiation protection. Experiments
by Bauer (1995, 1996, 2000) and Belyakov et al. (2001, 2002, 2003) sug-
gest that apoptosis and cell differentiation may be important radiopro-
tective mechanisms and additional work is needed to integrate these and
other phenomena into multi-stage cancer models.
CONCLUSIONS
• Endogenous DNA damage should be considered in estimation of the
risks from low doses of ionizing radiation. Our studies suggest endoge-
nous damage may contribute significantly to the induction of lung can-
cer even for lifetime doses as high as 1 Gy.
• Based on a stochastic two-stage lung cancer model that considers
inducible DNA repair and radical scavenging together, radiation must
induce changes in repair and scavenging greater than 30 or 40% of
baseline values in order to produce significant deviations in the dose-
response curves for the lifetime probability for lung cancer.
• If only radical scavenging is considered, radiation must induce changes
of at least 200% of the baseline scavenger activity in order to produce
cumulative probability levels for lung cancer outside the range expect-
ed for endogenous processes and background radiation.
• If only DNA repair is considered, radiation must induce changes of at
least 50% of the baseline repair value in order to produce cumulative
probability levels for lung cancer outside the range expected for
endogenous processes and background radiation. DNA repair effects
are predicted to have a larger impact on lung cancer incidence than
radical scavenging.
• The model neglects many other biological processes that are potentially
important in low dose radiobiology, and additional work is needed. The
proposed model also needs to be extended to other types of exposure
conditions, such as low doses of low-LET radiation delivered at high
dose rates.
Radioprotective mechanisms within a two-stage cancer model
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